OLBA HEALTHCARE HOLDINGS (2689) Fundamentals 2026 — P/E 8.3x, Revenue Analysis | SniperIQ
OLBA HEALTHCARE HOLDINGS (2689) is a JP-listed Healthcare company in Medical - Distribution with a market capitalization of ¥11.4B, trading at ¥1927.00 on the JPX. This SniperIQ fundamentals page covers OLBA HEALTHCARE HOLDINGS's valuation (P/E 8.3x, P/B 0.9x), profitability (net margin 1.1%), revenue (¥122.7B in FY2024), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is OLBA HEALTHCARE HOLDINGS's market cap?
OLBA HEALTHCARE HOLDINGS (2689) has a market capitalization of approximately ¥11.4B, trading at ¥1927.00 on the JPX. Market cap moves with the live share price.
What is OLBA HEALTHCARE HOLDINGS's P/E ratio?
OLBA HEALTHCARE HOLDINGS's trailing twelve-month P/E ratio is 8.3x, with a price-to-book (P/B) of 0.9x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is OLBA HEALTHCARE HOLDINGS?
OLBA HEALTHCARE HOLDINGS runs a net profit margin of 1.1%, a gross margin of 11.3%, and an operating margin of 1.5%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does OLBA HEALTHCARE HOLDINGS generate?
OLBA HEALTHCARE HOLDINGS reported revenue of ¥122.7B for fiscal year 2024, with net income of ¥1.4B and earnings per share (EPS) of 241.43. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does OLBA HEALTHCARE HOLDINGS pay a dividend?
OLBA HEALTHCARE HOLDINGS offers a trailing dividend yield of about 4.2%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is OLBA HEALTHCARE HOLDINGS financially healthy?
OLBA HEALTHCARE HOLDINGS carries a debt-to-equity ratio of 0.27x and a current ratio of 1.20x, with a market beta of 0.26. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is OLBA HEALTHCARE HOLDINGS a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For OLBA HEALTHCARE HOLDINGS (2689) the key facts are: market cap ¥11.4B, P/E 8.3x, revenue ¥122.7B, 52-week range 1780-2238. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track OLBA HEALTHCARE HOLDINGS's full fundamentals live
Get OLBA HEALTHCARE HOLDINGS's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.